Virology News and Research

Latest Virology News and Research

Gilead, MicroDose enter collaboration for inhalable small molecule antiviral fusion inhibitor MDT-637

Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).

20 Apr 2011

Roche's cobas HPV Test receives FDA approval for cervical cancer screening

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent many women from developing this deadly disease.

From Roche Sequencing and Life Science 20 Apr 2011

Oncolytics announces interim data from REOLYSIN translational clinical trial in metastatic colorectal cancer

Oncolytics Biotech Inc. today announced interim data from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases. The principal investigator of the study was Professor Alan Melcher of Leeds Institute of Molecular Medicine, University of Leeds, UK.

20 Apr 2011

LMP1 viral protein needs TRAF6 cellular protein to promote B cell activation signaling pathways: Study

By identifying a surprising association of two intracellular proteins, University of Iowa researchers have laid the groundwork for the development of new therapies to treat B cell lymphomas and autoimmune disease.

20 Apr 2011

Study shows possibility of women living with AIDS to breastfeed with lower risk

In low-income countries, 1.4 million women are living with the Aids virus. If no prevention measures are taken, the risk for future mothers of transmitting HIV to their child in utero, during delivery or when breastfeeding is 35%.

20 Apr 2011

Researchers to wind down HIV prevention trial in women after interim results find drug not offering protection from HIV

Researchers on Monday announced they were calling off a trial to test whether taking an oral HIV drug reduces the risk of HIV infection in women after interim analysis of the study showed women taking the medication were no less likely to become infected with HIV than those who were not taking the medicine, the Associated Press reports.

20 Apr 2011

Chronic inflammation due to infection may lead to cancer

A new study shows how inflammation can help cause cancer. Chronic inflammation due to infection or to conditions such as chronic inflammatory bowel disease is associated with up to 25 percent of all cancers.

20 Apr 2011

FHI to stop FEM-PrEP study of HIV prevention among heterosexual women

On the heels of Centers for Disease Control announcement earlier today that an ongoing study of the use of Gilead's top selling AIDS treatment, Truvada, as a possible form of pre-exposure prophylaxis for HIV prevention in women is being abruptly halted because the, "…trial could not demonstrate efficacy," the AIDS Healthcare Foundation renewed its call on Gilead Sciences to slow its fast track pursuit of its application for FDA approval of use of its AIDS drug as a possible form of HIV prevention.

20 Apr 2011

Cervical cancer vaccine target falls short: Report

Data from the Australian federal government shows that the target to immunize 80 per cent of 12-year-old girls against cervical cancer is not being met because many of them are failing to have all three doses of the vaccine. This potentially undermines the effectiveness of the $436 million program started in 2007.

19 Apr 2011

African AIDS drug trial stopped prematurely

One of the studies in three African countries where women were given an AIDS drug to prevent HIV infection is being stopped because the project is not working, researchers said Monday. These women on the trial were taking a daily dose of the drug Truvada or a look-alike placebo pill and had an equal chance of becoming infected. The ones taking Truvada were expected to have had a much lower infection rate.

19 Apr 2011

Countries agree to draft framework on virus sharing, WHO says

After almost four years of negotiations, the WHO on Saturday announced it had reached an agreement on sharing flu virus samples, Agence-France Presse reports.

19 Apr 2011

People with infectious mononucleosis, low UVB exposure may face high risk of MS

New research suggests that people who are exposed to low levels of sunlight coupled with a history of having a common virus known as mononucleosis may be at greater odds of developing multiple sclerosis than those without the virus.

19 Apr 2011

NIH awards U of M's scientist with $10 million grant for HIV research

Reuben Harris, professor in the University of Minnesota's College of Biological Sciences, has been awarded a five-year, $10 million grant from the National Institutes of Health to direct a large-scale research effort to study a human antiviral protein with potential for treating HIV and other viral diseases.

19 Apr 2011

Roche introduces new EMR interface for the U.S. Department of VA

Roche announced today that it has introduced a new Electronic Medical Record interface for the U.S. Department of Veterans Affairs that helps VA healthcare facilities improve their efficiency and accuracy by transmitting patient diabetes management data directly into the VistA computerized patient record system.

From Roche Sequencing and Life Science 19 Apr 2011

Groundbreaking news on Dengue

Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.

18 Apr 2011

Quest Diagnostics launches AccuType IL28B test for HCV

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.

From Quest Diagnostics 18 Apr 2011

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

18 Apr 2011

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today it has signed a collaboration agreement with Transgene S.A. and ChronTech Pharma AB to evaluate a novel therapeutic vaccination strategy against genotype 1 hepatitis C virus in a phase I clinical study.

18 Apr 2011

CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status

Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.

18 Apr 2011

Virus-sharing draft agreement very close; U.S. yet to formally approve, Reuters reports

A draft agreement that would ensure countries would share virus samples in exchange for access to affordable vaccines derived from such samples in the event of a pandemic is nearly complete, senior diplomats told Reuters on Thursday.

16 Apr 2011

Virology News and Research

Latest Virology News and Research

Gilead, MicroDose enter collaboration for inhalable small molecule antiviral fusion inhibitor MDT-637

Roche's cobas HPV Test receives FDA approval for cervical cancer screening

Oncolytics announces interim data from REOLYSIN translational clinical trial in metastatic colorectal cancer

LMP1 viral protein needs TRAF6 cellular protein to promote B cell activation signaling pathways: Study

Study shows possibility of women living with AIDS to breastfeed with lower risk

Researchers to wind down HIV prevention trial in women after interim results find drug not offering protection from HIV

Chronic inflammation due to infection may lead to cancer

FHI to stop FEM-PrEP study of HIV prevention among heterosexual women

Cervical cancer vaccine target falls short: Report

African AIDS drug trial stopped prematurely

Countries agree to draft framework on virus sharing, WHO says

People with infectious mononucleosis, low UVB exposure may face high risk of MS

NIH awards U of M's scientist with $10 million grant for HIV research

Roche introduces new EMR interface for the U.S. Department of VA

Groundbreaking news on Dengue

Quest Diagnostics launches AccuType IL28B test for HCV

Study: Borna disease virus does not contain exact copies of genomic RNAs

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status

Virus-sharing draft agreement very close; U.S. yet to formally approve, Reuters reports

Microplate-based assays in virology research eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging